What Inspira IINNW management is not saying enough about 013 20260508 ATHE Alterity publishes latest quarterly earnings report outlining new advancement plans for its lead neurological drug candidate Is Aclarion ACON stock suitable for your portfolio 326 20260429 The recurring revenue story behind Arc Tx ARCT Q1 2026 EPS Exceeds Expectations